Kazia Therapeutics Limited Made Headway
Kazia Therapeutics Limited (KZIA:NASDAQ) rocketted at $1.24, representing a gain of 85.6%. On Thu, Jul 11, 2024, KZIA:NASDAQ touched a New 2-Week High of $1.24. The stock got featured on our News Catalysts scanner on Thu, Jul 11, 2024 at 08:02 AM in the 'MISCELLANEOUS' category. From Thu, Jun 27, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Thu, Jul 11, 2024 at $1.58 with a volume of 223M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Locafy Limited (LCFY:NASDAQ), 158.47%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 85.57%
- Cyngn Inc. (CYN:NASDAQ), 85.1%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75%
- NexImmune Inc. (NEXI:NASDAQ), 68.67%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 51.88%
- Methode Electronics, Inc. (MEI:NYSE), 45.76%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 38.04%